Dual-functionalisation of gelatine nanoparticles with an anticancer platinum(ii)–bisphosphonate complex and mineral-binding alendronate-Reference-Cited by-同舟云学术

Dual-functionalisation of gelatine nanoparticles with an anticancer platinum(ii)–bisphosphonate complex and mineral-binding alendronate

Published:2016 Issue:114 Volume:6 Page:113025-113037
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Farbod Kambiz¹²³⁴⁵^ORCID,Curci Alessandra⁶⁷⁸⁹,Diba Mani¹²³⁴⁵,Zinkevich Tatiana¹⁰¹¹¹²¹³⁵,Kentgens Arno P. M.¹⁰¹¹¹²¹³⁵,Iafisco Michele¹⁴¹⁵¹⁶⁹,Margiotta Nicola⁶⁷⁸⁹,Leeuwenburgh Sander C. G.¹²³⁴⁵

Affiliation:

1. Department of Biomaterials

2. Radboud Institute for Molecular Life Sciences

3. Radboud University Medical Center

4. 6525 EX Nijmegen

5. The Netherlands

6. Dipartimento di Chimica

7. Università degli Studi di Bari Aldo Moro

8. 70125 Bari

9. Italy

10. Department of Solid State NMR

11. Institute for Molecules and Materials

12. Radboud University

13. 6525 AJ Nijmegen

14. Institute of Science and Technology for Ceramics (ISTEC)

15. National Research Council (CNR)

16. 48018 Faenza

Abstract

Mineral-binding gelatine nanoparticles can be loaded with tailored amounts of anticancer molecules, which may benefit the development of bone-seeking carriers for targeted delivery of drugs to treat bone tumours.

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA19915A

Reference76 articles.

1. Incidence of bone metastases in breast cancer patients in the United Kingdom: Results of a multi-database linkage study using the general practice research database

2. Radioisotopes for the palliation of metastatic bone cancer: a systematic review

3. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial